Go Pro
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free SOPH Stock Alerts

SOPHiA GENETICS (SOPH) Financials

SOPHiA GENETICS logo
$5.65 -0.17 (-2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$5.66 +0.01 (+0.18%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for SOPHiA GENETICS

Annual Income Statements for SOPHiA GENETICS

This table shows SOPHiA GENETICS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -34 -39 -74 -87 -79 -62 -79
Consolidated Net Income / (Loss)		 -34 -39 -74 -87 -79 -62 -79
Net Income / (Loss) Continuing Operations		 -34 -39 -74 -87 -79 -62 -79
Total Pre-Tax Income 		-34 -41 -74 -88 -78 -61 -77
Total Operating Income		 -32 -37 -71 -88 -75 -67 -71
Total Gross Profit		 18 18 25 31 43 44 52
Total Revenue		 25 28 40 48 62 65 77
Operating Revenue		 25 28 40 48 62 65 77
Total Cost of Revenue		 7.53 11 15 16 19 21 25
Operating Cost of Revenue		 7.53 11 15 16 19 21 25
Total Operating Expenses		 50 55 97 119 118 111 123
Selling, General & Admin Expense		 16 19 42 56 53 47 53
Marketing Expense		 19 17 29 28 28 29 36
Research & Development Expense		 15 19 27 35 37 34 34
Other Operating Expenses / (Income)		 0.02 0.09 -0.11 -0.38 -0.95 -0.18 0.09
Total Other Income / (Expense), net		 -1.34 -3.84 -2.02 0.69 -3.67 5.30 -6.58
Interest Expense		 - - 0.64 0.64 0.59 1.91 4.55
Interest & Investment Income		 - - - 1.32 4.55 3.73 1.38
Other Income / (Expense), net		 - - -1.38 - -7.63 3.48 -3.40
Income Tax Expense		 0.16 -1.89 0.17 -0.14 0.49 1.22 1.51
Weighted Average Basic Shares Outstanding		 - - 63.86M 64.23M 65.23M 66.69M 68.49M
Diluted Earnings per Share		 ($0.90) ($0.93) - ($1.36) ($1.22) ($0.95) ($1.17)
Weighted Average Diluted Shares Outstanding		 - - 63.86M 64.23M 65.23M 66.69M 68.49M
Weighted Average Basic & Diluted Shares Outstanding		 - - 63.86M 64.23M 65.23M 66.69M 68.49M

Quarterly Income Statements for SOPHiA GENETICS

No quarterly income statements for SOPHiA GENETICS are available.

Annual Cash Flow Statements for SOPHiA GENETICS

This table details how cash moves in and out of SOPHiA GENETICS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -36 51 42 82 -43 -39 -14
Net Cash From Operating Activities		 -32 -32 20 3.68 -53 -45 -36
Net Cash From Continuing Operating Activities		 -31 -34 20 3.68 -55 -38 -41
Net Income / (Loss) Continuing Operations		 -34 -41 0.00 0.00 -78 -61 -77
Consolidated Net Income / (Loss)		 -34 -41 - - -78 -61 -77
Depreciation Expense		 - 1.76 2.52 3.79 5.51 4.58 3.98
Amortization Expense		 - 0.63 1.09 1.78 2.83 4.02 5.55
Non-Cash Adjustments To Reconcile Net Income		 1.70 4.18 7.83 -0.47 17 15 17
Changes in Operating Assets and Liabilities, net		 0.45 0.58 8.98 -1.43 -1.00 -0.34 11
Net Cash From Investing Activities		 -3.03 -24 22 79 13 -4.76 -8.67
Net Cash From Continuing Investing Activities		 -3.03 -0.77 22 79 20 2.98 -0.73
Purchase of Property, Plant & Equipment		 -1.36 -0.45 - - -1.76 -0.44 -0.68
Purchase of Investments		 -1.68 -0.32 - - 0.00 0.00 -1.89
Sale and/or Maturity of Investments		 - - 22 79 22 3.42 1.84
Net Cash From Financing Activities		 -1.02 107 0.00 0.00 -2.82 9.86 30
Net Cash From Continuing Financing Activities		 -0.82 107 0.00 0.00 -2.82 9.86 30
Repayment of Debt		 -0.82 -18 - - -3.05 -4.48 -5.83
Issuance of Debt		 - 16 - - 0.00 14 35
Issuance of Common Equity		 0.00 108 - - 0.00 0.00 1.09
Other Financing Activities, net		 - 1.07 - - 0.23 0.41 0.35

Quarterly Cash Flow Statements for SOPHiA GENETICS

No quarterly cash flow statements for SOPHiA GENETICS are available.

Annual Balance Sheets for SOPHiA GENETICS

This table presents SOPHiA GENETICS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 132 320 244 206 155 163
Total Current Assets		 110 283 196 148 99 99
Cash & Equivalents		 75 193 161 123 80 70
Accounts Receivable		 6.36 6.28 6.65 14 7.44 15
Inventories, net		 3.38 5.73 5.16 6.48 5.87 6.35
Prepaid Expenses		 2.60 5.53 5.84 4.76 5.88 7.44
Plant, Property, & Equipment, net		 1.77 4.66 7.13 7.47 5.21 5.67
Plant, Property & Equipment, gross		 1.77 4.66 7.13 7.47 5.21 5.67
Total Noncurrent Assets		 21 33 40 51 51 58
Intangible Assets		 13 16 20 27 29 36
Noncurrent Deferred & Refundable Income Taxes		 2.11 1.99 1.94 1.72 1.77 1.83
Other Noncurrent Operating Assets		 5.25 15 19 22 20 21
Total Liabilities & Shareholders' Equity		 132 320 244 206 155 163
Total Liabilities		 32 45 44 55 59 116
Total Current Liabilities		 22 29 27 23 18 30
Accounts Payable		 5.91 6.74 6.18 5.39 5.22 8.96
Accrued Expenses		 - - - 18 13 21
Total Noncurrent Liabilities		 10 16 17 32 40 86
Long-Term Debt		 0.46 0.00 - 0.00 13 48
Capital Lease Obligations		 2.88 11 14 19 17 15
Noncurrent Deferred Revenue		 0.14 0.00 - 9.49 5.73 17
Noncurrent Employee Benefit Liabilities		 - 4.45 2.68 3.09 3.84 4.16
Other Noncurrent Operating Liabilities		 1.38 0.47 0.17 0.33 0.78 2.29
Total Equity & Noncontrolling Interests		 101 275 200 151 96 47
Total Preferred & Common Equity		 101 275 200 151 96 47
Total Common Equity		 -127 -195 -271 151 96 47
Common Stock		 2.46 3.33 3.46 4.05 4.19 4.81
Retained Earnings		 -138 -211 -299 -378 -440 -519
Treasury Stock		 - 0.00 -0.12 -0.65 -0.70 -1.22
Other Equity Adjustments		 8.30 13 24 526 533 563

Quarterly Balance Sheets for SOPHiA GENETICS

No quarterly balance sheets for SOPHiA GENETICS are available.

Annual Metrics And Ratios for SOPHiA GENETICS

This table displays calculated financial ratios and metrics derived from SOPHiA GENETICS's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 63,857,604.00 64,231,220.00 65,230,559.00 - 68,486,338.00
DEI Adjusted Shares Outstanding		 0.00 0.00 63,857,604.00 64,231,220.00 65,230,559.00 - 68,486,338.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -1.15 -1.36 -1.21 - -1.15
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -23 -26 -50 -61 -52 -47 -50
Return On Investment Capital (ROIC_SIMPLE)		 - - - -28.70% -30.80% -36.83% -45.05%
Earnings before Interest and Taxes (EBIT)		 -32 -37 -73 -88 -82 -63 -74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -32 -35 -69 -82 -74 -54 -65
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -73 -113 -19 -32 -46 -43
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 46 110 67 47 46 40
Increase / (Decrease) in Invested Capital		 0.00 46 63 -42 -21 -0.50 -6.42
Book Value per Share		 $0.00 ($9.76) ($3.06) ($4.25) $2.36 $1.48 $0.71
Tangible Book Value per Share		 $0.00 ($10.78) ($3.31) ($4.56) $1.93 $1.03 $0.17
Total Capital		 0.00 107 287 214 170 127 110
Total Debt		 0.00 6.21 11 14 19 30 63
Total Long-Term Debt		 0.00 3.34 11 14 19 30 63
Net Debt		 0.00 -68 -182 -147 -105 -50 -7.27
Capital Expenditures (CapEx)		 1.36 0.45 0.00 0.00 1.76 0.44 0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 16 61 8.14 1.60 0.74 -0.91
Debt-free Net Working Capital (DFNWC)		 0.00 91 254 169 125 81 69
Net Working Capital (NWC)		 0.00 88 254 169 125 81 69
Net Nonoperating Expense (NNE)		 11 13 24 26 27 16 29
Net Nonoperating Obligations (NNO)		 0.00 -54 -166 -133 -105 -50 -7.27
Total Depreciation and Amortization (D&A)		 0.00 2.39 3.61 5.57 8.34 8.60 9.53
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.33) ($1.36) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 63.86M 64.23M 65.23M 66.69M 68.49M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.33) ($1.36) $0.00 ($0.95) ($1.17)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 63.86M 64.23M 65.23M 66.69M 68.49M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.33) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 63.86M 64.23M 65.23M 66.69M 68.49M
Normalized Net Operating Profit after Tax (NOPAT)		 -23 -26 -50 -61 -52 -47 -50
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for SOPHiA GENETICS

No quarterly metrics and ratios for SOPHiA GENETICS are available.


Financials Breakdown Chart

SOPHiA GENETICS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SOPHiA GENETICS's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

SOPHiA GENETICS's net income appears to be on an upward trend, with a most recent value of -$79.00 million in 2025, rising from -$33.79 million in 2019. The previous period was -$62.49 million in 2024. Find out what analysts predict for SOPHiA GENETICS in the coming months.

SOPHiA GENETICS's total operating income in 2025 was -$70.91 million, based on the following breakdown:
  • Total Gross Profit: $52.08 million
  • Total Operating Expenses: $122.98 million

Over the last 6 years, SOPHiA GENETICS's total revenue changed from $25.36 million in 2019 to $77.27 million in 2025, a change of 204.7%.

SOPHiA GENETICS's total liabilities were at $115.89 million at the end of 2025, a 97.0% increase from 2024, and a 266.7% increase since 2020.

In the past 5 years, SOPHiA GENETICS's cash and equivalents has ranged from $70.29 million in 2025 to $192.96 million in 2021, and is currently $70.29 million as of their latest financial filing in 2025.

Over the last 6 years, SOPHiA GENETICS's book value per share changed from 0.00 in 2019 to 0.71 in 2025, a change of 70.7%.


Related Companies

Financial statements for NASDAQ:SOPH last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Is the fix for AI's runaway power problem your golden ticket?
The government just committed $200 billion to building computer chips on American soil - one of the largest te...
Eagle Publishing | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Executive order could send gold to 6,000 per ounce
Executive Order 14330 will allow Americans to hold precious metals inside 401(k)s for the first time ever - an...
Cedar Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...
Profits Run | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel